MX2009004170A - Materiales y metodos para inmunoglicoproteinas mejoradas. - Google Patents
Materiales y metodos para inmunoglicoproteinas mejoradas.Info
- Publication number
- MX2009004170A MX2009004170A MX2009004170A MX2009004170A MX2009004170A MX 2009004170 A MX2009004170 A MX 2009004170A MX 2009004170 A MX2009004170 A MX 2009004170A MX 2009004170 A MX2009004170 A MX 2009004170A MX 2009004170 A MX2009004170 A MX 2009004170A
- Authority
- MX
- Mexico
- Prior art keywords
- castanospermine
- dependent cytotoxicity
- increasing antibody
- immunoglycoproteins
- antibody
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2887—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against CD20
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2896—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against molecules with a "CD"-designation, not provided for elsewhere
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
- C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
- C07K2317/622—Single chain antibody (scFv)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/72—Increased effector function due to an Fc-modification
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
- C07K2317/732—Antibody-dependent cellular cytotoxicity [ADCC]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
- C07K2317/734—Complement-dependent cytotoxicity [CDC]
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Las inmunoglicoproteínas incluyen anticuerpos, con una ADCC (citotoxicidad dependiente de anticuerpos) mejorada y se proveen patrones de glicosilación alterados. También se proporcionan métodos de cultivo celular y los medios para producir tales inmunoglicoproteínas y usos terapéuticos de tales inmunoglicoproteínas.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US85394406P | 2006-10-24 | 2006-10-24 | |
| PCT/US2007/082343 WO2008052030A2 (en) | 2006-10-24 | 2007-10-24 | A method for increasing antibody-dependent cytotoxicity with castanospermine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2009004170A true MX2009004170A (es) | 2009-06-26 |
Family
ID=39204867
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2009004170A MX2009004170A (es) | 2006-10-24 | 2007-10-24 | Materiales y metodos para inmunoglicoproteinas mejoradas. |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US20100150948A1 (es) |
| EP (1) | EP2076538A2 (es) |
| JP (1) | JP2010507394A (es) |
| CN (1) | CN101646688A (es) |
| AU (1) | AU2007308983B2 (es) |
| BR (1) | BRPI0717601A2 (es) |
| CA (1) | CA2663536A1 (es) |
| MX (1) | MX2009004170A (es) |
| WO (1) | WO2008052030A2 (es) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030133939A1 (en) | 2001-01-17 | 2003-07-17 | Genecraft, Inc. | Binding domain-immunoglobulin fusion proteins |
| US7754208B2 (en) | 2001-01-17 | 2010-07-13 | Trubion Pharmaceuticals, Inc. | Binding domain-immunoglobulin fusion proteins |
| AU2006272555B2 (en) | 2005-07-25 | 2012-03-08 | Aptevo Research And Development Llc | B-cell reduction using CD37-specific and CD20-specific binding molecules |
| CN105837690A (zh) | 2006-06-12 | 2016-08-10 | 新兴产品开发西雅图有限公司 | 具有效应功能的单链多价结合蛋白 |
| US7846434B2 (en) * | 2006-10-24 | 2010-12-07 | Trubion Pharmaceuticals, Inc. | Materials and methods for improved immunoglycoproteins |
| NZ603059A (en) | 2008-04-11 | 2014-07-25 | Emergent Product Dev Seattle | Cd37 immunotherapeutic and combination with bifunctional chemotherapeutic thereof |
| PL2282773T3 (pl) † | 2008-05-02 | 2014-08-29 | Seattle Genetics Inc | Sposoby i kompozycje do wytwarzania przeciwciał i pochodnych przeciwciał o obniżonej fukozylacji rdzeniowej |
| AU2009298131B2 (en) | 2008-10-02 | 2016-07-14 | Aptevo Research And Development Llc | CD86 antagonist multi-target binding proteins |
| JP2014501097A (ja) * | 2009-07-06 | 2014-01-20 | アルナイラム ファーマシューティカルズ, インコーポレイテッド | 生物由来物質の産生を高めるための組成物及び方法 |
| EP2516467A2 (en) | 2009-12-23 | 2012-10-31 | Emergent Product Development Seattle, LLC | Compositions comprising tnf-alpha and il-6 antagonists and methods of use thereof |
| US20130089554A1 (en) | 2009-12-29 | 2013-04-11 | Emergent Product Development Seattle, Llc | RON Binding Constructs and Methods of Use Thereof |
| LT2544719T (lt) | 2010-03-12 | 2019-10-25 | Debiopharm Int Sa | Cd37 surišančios molekulės, ir jų imunokonjugatai |
| EP3513794A3 (en) | 2010-08-05 | 2019-10-16 | Seattle Genetics, Inc. | Fucose analogs for inhibition of protein fucosylation in vivo |
| AU2012236210B2 (en) | 2011-04-01 | 2016-02-04 | Immunogen, Inc. | CD37-binding molecules and immunoconjugates thereof |
| EP2887947B1 (en) | 2012-08-23 | 2019-06-05 | Seattle Genetics, Inc. | Fucose analogues for the treatment of sickle cell disease |
| SI3063287T1 (sl) * | 2013-10-31 | 2025-06-30 | Amgen, Inc. | Uporaba monenzina za regulacijo glikozilacije rekombinantnih proteinov |
| BR112017026027A2 (pt) | 2015-06-08 | 2018-08-14 | Debiopharm Int Sa | combinações de imunoconjugado anti-cd37 e anticorpo anti-cd20 |
| JP6890581B2 (ja) | 2015-08-28 | 2021-06-18 | デビオファーム インターナショナル, エス. アー. | Cd37の検出のための抗体およびアッセイ |
| HK1251480A1 (zh) | 2015-09-21 | 2019-02-01 | Aptevo Research And Development Llc | Cd3结合多肽 |
| US11278629B2 (en) | 2016-11-02 | 2022-03-22 | Debiopharm International, S.A. | Methods for improving anti-CD37 immunoconjugate therapy |
| CN110072890B (zh) | 2016-11-03 | 2022-11-29 | 百时美施贵宝公司 | 可活化的抗ctla-4抗体及其用途 |
| AU2018235928B2 (en) | 2017-03-14 | 2023-09-21 | Amgen Inc. | Control of total afucosylated glycoforms of antibodies produced in cell culture |
| US12325737B2 (en) | 2018-03-26 | 2025-06-10 | Amgen Inc. | Total afucosylated glycoforms of antibodies produced in cell culture |
| AU2019277836A1 (en) | 2018-05-30 | 2021-01-21 | Debiopharm International, S.A. | Anti-CD37 immunoconjugate dosing regimens |
| CA3123591A1 (en) * | 2018-12-19 | 2020-06-25 | Seagen Inc. | Controlled fucosylation of antibodies |
| WO2025245176A1 (en) | 2024-05-22 | 2025-11-27 | Bristol-Myers Squibb Company | Multispecific antibody constructs |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5605690A (en) * | 1989-09-05 | 1997-02-25 | Immunex Corporation | Methods of lowering active TNF-α levels in mammals using tumor necrosis factor receptor |
| EP0503648B1 (en) * | 1991-03-12 | 2000-06-07 | Biogen, Inc. | CD2-Binding domain of lymphocyte function associated antigen 3 |
| US6737056B1 (en) * | 1999-01-15 | 2004-05-18 | Genentech, Inc. | Polypeptide variants with altered effector function |
| US7560534B2 (en) * | 2000-05-08 | 2009-07-14 | Celldex Research Corporation | Molecular conjugates comprising human monoclonal antibodies to dendritic cells |
| DE60131456T2 (de) * | 2000-11-30 | 2008-07-10 | Medarex, Inc., Milpitas | Transchromosomale transgen-nagetiere zur herstellung von humanen antikörpern |
| US6979556B2 (en) * | 2000-12-14 | 2005-12-27 | Genentech, Inc. | Separate-cistron contructs for secretion of aglycosylated antibodies from prokaryotes |
| US20030133939A1 (en) * | 2001-01-17 | 2003-07-17 | Genecraft, Inc. | Binding domain-immunoglobulin fusion proteins |
| US7754208B2 (en) * | 2001-01-17 | 2010-07-13 | Trubion Pharmaceuticals, Inc. | Binding domain-immunoglobulin fusion proteins |
| US7829084B2 (en) * | 2001-01-17 | 2010-11-09 | Trubion Pharmaceuticals, Inc. | Binding constructs and methods for use thereof |
| JP4213586B2 (ja) * | 2001-09-13 | 2009-01-21 | 株式会社抗体研究所 | ラクダ抗体ライブラリーの作製方法 |
| PL213948B1 (pl) * | 2001-10-25 | 2013-05-31 | Genentech Inc | Kompozycje zawierajace glikoproteine, czasteczka kwasu nukleinowego kodujaca te glikoproteine, komórka gospodarza, sposób wytwarzania glikoproteiny, kompozycja do zastosowania do leczenia, zastosowanie kompozycji i zestaw zawierajacy kompozycje |
| US20040038304A1 (en) * | 2002-03-28 | 2004-02-26 | Gala Design, Inc. | Antibody libraries |
| ES2327830T3 (es) * | 2002-03-29 | 2009-11-04 | Schering Corporation | Anticuerpos monoclonales humanos anti-interleuquina-5 y metodos y composiciones que los contienen. |
| US20060127404A1 (en) * | 2003-09-30 | 2006-06-15 | Chichi Huang | Hinge core mimetibodies, compositions, methods and uses |
| EP1689878A4 (en) * | 2003-11-03 | 2007-02-14 | Centocor Inc | METHOD FOR MAINTAINING LOW SHEAR IN A BIOTECHNOLOGICAL SYSTEM |
| AU2006272555B2 (en) * | 2005-07-25 | 2012-03-08 | Aptevo Research And Development Llc | B-cell reduction using CD37-specific and CD20-specific binding molecules |
| DK1945665T3 (da) * | 2005-10-21 | 2012-02-06 | Genzyme Corp | Antistof-baserede terapimidler med forhøjet ADCC-aktivitet |
-
2007
- 2007-10-24 CA CA002663536A patent/CA2663536A1/en not_active Abandoned
- 2007-10-24 BR BRPI0717601-5A patent/BRPI0717601A2/pt not_active IP Right Cessation
- 2007-10-24 US US12/446,714 patent/US20100150948A1/en not_active Abandoned
- 2007-10-24 MX MX2009004170A patent/MX2009004170A/es active IP Right Grant
- 2007-10-24 JP JP2009534837A patent/JP2010507394A/ja not_active Ceased
- 2007-10-24 EP EP07844563A patent/EP2076538A2/en not_active Ceased
- 2007-10-24 WO PCT/US2007/082343 patent/WO2008052030A2/en not_active Ceased
- 2007-10-24 AU AU2007308983A patent/AU2007308983B2/en not_active Ceased
- 2007-10-24 CN CN200780039452A patent/CN101646688A/zh active Pending
-
2013
- 2013-06-14 US US13/918,585 patent/US20130280240A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| AU2007308983A1 (en) | 2008-05-02 |
| BRPI0717601A2 (pt) | 2013-10-22 |
| US20130280240A1 (en) | 2013-10-24 |
| WO2008052030A3 (en) | 2008-06-12 |
| AU2007308983B2 (en) | 2012-12-06 |
| EP2076538A2 (en) | 2009-07-08 |
| CN101646688A (zh) | 2010-02-10 |
| WO2008052030A2 (en) | 2008-05-02 |
| JP2010507394A (ja) | 2010-03-11 |
| US20100150948A1 (en) | 2010-06-17 |
| CA2663536A1 (en) | 2008-05-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2008052030A3 (en) | A method for increasing antibody-dependent cytotoxicity with castanospermine | |
| WO2009126858A3 (en) | Materials and methods for improved immunoglycoproteins | |
| EP2007386A4 (en) | CAMPTOTHECIN ANALOGUE HAVING A NEW LACTONE STABLE RETURNED "RETURNED" CORE AND METHODS FOR PREPARING AND USING SAME | |
| EP2068389B8 (en) | Method for producing separator for fuel cell, separator for fuel cell, and fuel cell | |
| MX2007008506A (es) | Metodos y productos para genotipificacion in vitro. | |
| EP1901127A4 (en) | BINDER RESIN FOR TONER, TONER AND PROCESS FOR PREPARING THE BINDER RESIN FOR TONER | |
| MX300732B (es) | Celulasas, acidos nucleicos que las codifican y metodos para hacerlas y usarlas. | |
| EP2094844A4 (en) | IMPROVED BUTANOL PRODUCING MICROORGANISMS AND METHOD FOR THE PRODUCTION OF BUTANOL THEREWITH | |
| IL180125A0 (en) | Methods for producing biodiesel | |
| IL197459A (en) | Manned proteins, including antibodies, and methods for their preparation | |
| EP2028172A4 (en) | PROCESS FOR PRODUCING 1,3,3,3-TETRAFLUOROPROPENE | |
| WO2009126350A3 (en) | Methods and compositions for targeting k63-linked polyubiquitin | |
| TWI318298B (en) | Method for manufacturing a conductive contacter holder, and the conductive contacter holder | |
| WO2007011742A3 (en) | Cigs photovoltaic cells | |
| AP2290A (en) | Method of producing a booklet, data page produced by this method and booklet by the method. | |
| EP2119518A4 (en) | FINE SILVER POWDER | |
| EP1911538A4 (en) | EDGE REPLACEMENT CUTTING HEAD AND METHOD FOR PRODUCING THE SAME | |
| MX2007004642A (es) | Combinaciones polimericas para producir peliculas con un numero reducido de defectos. | |
| EP2014824B8 (en) | Reinforcing cord, method for producing the same, and product using the reinforcing cord | |
| WO2008086228A3 (en) | Arrays and methods for guided cell patterning | |
| MX280092B (es) | Proceso para producir un compuesto de 5 - hidroxi - 4 - tiometilpirazol. | |
| WO2006044754A3 (en) | Process for preparing telmisartan | |
| PT2225314T (pt) | Silicones-autoadesivos, método de fabrico, complexos que os utilizam e aplicações | |
| PL1985176T3 (pl) | Zabarwiona żyłka wędkarska i proces jej wytwarzania | |
| SG129313A1 (en) | Carbon black, method for producing the same, and its use |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |